According to Fierce Biotech's Maureen Martino and BNet Pharma, the next round of purchases in the biotech sphere will likely focus on some or all of these target companies to gain access to existingdrugs or their pipelines.
The most likely candidates include: Vertex Pharmaceuticals, Human Genome Sciences, Alexion Pharmaceuticals, United Therapeutics, Onyx Pharmaceuticals, Auxilion Pharmacueticals, and Allos Therapeutics.
Place your bets on who will buy and be bought.
Careful with this video. "Who Will Buy?" from Oliver! It is 9 minutes long. It has nothing to do with the industry but maybe will perk you up for the day.
Posted by Bruce Lehr March 13, 2010